AdvisorShares Psychedelics ETF (PSIL)

NYSEARCA: PSIL · IEX Real-Time Price · USD
2.87
+0.12 (4.36%)
Oct 4, 2022 10:34 AM EDT - Market open
4.36%
Assets $5.91M
NAV $2.62
Expense Ratio 0.68%
PE Ratio n/a
Shares Out 2.26M
Dividend (ttm) $0.05
Dividend Yield 1.88%
Ex-Dividend Date Sep 26, 2022
1-Year Return -69.36%
Volume 19,012
Open 2.89
Previous Close 2.75
Day's Range 2.85 - 3.00
52-Week Low 2.50
52-Week High 10.70
Beta 1.41
Holdings 33
Inception Date Sep 15, 2021

About PSIL

The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.

Asset Class Equity
Region Global
Issuer Advisors Asset Management
Stock Exchange NYSEARCA
Ticker Symbol PSIL

Top 10 Holdings

66.94% of assets
Name Symbol Weight
COMPASS Pathways CMPS 11.76%
Cybin Inc Ordinary Shares CYBN.NE 8.94%
ATAI Life Sciences ATAI 8.01%
Blackrock Treasury Trust Instl 62 n/a 6.88%
Seelos Therapeutics SEEL 6.51%
Relmada Therapeutics RLMD 5.37%
Sage Therapeutics SAGE 4.99%
FSD Pharma Inc Ordinary Shares - Class B (Sub Voting) HUGE.CN 4.91%
GH Research GHRS 4.84%
Intra-Cellular Therapies ITCI 4.73%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Sep 26, 2022 $0.054 Sep 30, 2022
Full Dividend History

News

Best-Performing ETFs of August Up At Least 15%

These ETFs gained at least 15% in the downbeat month of August.

Other symbols: KSETTUR
1 month ago - Zacks Investment Research

5 Top-Performing Sector ETFs of August

The month of August was marked by ups and downs.

Other symbols: IEOMJUSURNM
1 month ago - Zacks Investment Research

7 Psychedelics Stocks to Buy for a Big Drug Boom

Psychedelics stocks are becoming increasingly mainstream, in part due to changing social attitudes. Psychedelic drugs “are a loosely grouped class of drugs that are able to induce altered thoughts and s...

1 month ago - InvestorPlace